Predictive value of lymphocyte subsets and lymphocyte-to-monocyte ratio in assessing the efficacy of neoadjuvant therapy in breast cancer
Article in Scientific Reports (June 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway
Article in Cell Death & Disease (April 2024)
Engineered Tumor–Immune Microenvironment On A Chip to Study T Cell–Macrophage Interaction in Breast Cancer Progression
Article in Advanced Healthcare Materials (February 2024)